From: Development and validation of a psychosocial screening instrument for cancer
Cancer Type | Subscale – Mean (SD) | |||||
---|---|---|---|---|---|---|
 | Depression | Anxiety | QoL-P | QoL-D | SS-Tot | SS-Des |
Gastro-Intestinal | Â | Â | Â | Â | Â | Â |
   Female (n = 39) | 18.3 (12.9) | 8.4 (3.7) | 6.2 (5.7) | 26.7 (23.9) | 4.9 (.5) | 4.0 (3.9) |
   Male (n = 39) | 13.3 (4.4) | 6.7 (2.7) | 7.1 (4.6) | 31.3 (21.7) | 4.9 (.4) | 2.7 (3.5) |
Lung | Â | Â | Â | Â | Â | Â |
   Female (n = 35) | 17.6 (8.6) | 9.2 (4.5) | 8.7 (4.9) | 30.6 (22.9) | 4.0 (1.2) | 4.4 (3.6) |
   Male (n = 42) | 17.0 (6.9) | 8.9 (5.6) | 11.7 (6.1) | 41.3 (22.8) | 4.6 (.7) | 3.9 (3.2) |
Lymphoma | Â | Â | Â | Â | Â | Â |
   Female (n = 12) | 22.6 (8.6) | 12.1 (4.4) | 9.9 (7.9) | 35.6 (28.4) | 4.9 (.3) | 5.9 (4.0) |
   Male (n = 13) | 19.6 (11.9) | 9.6 (6.4) | 11.0 (6.6) | 35.0 (24.6) | 4.7 (.5) | 4.2 (3.9) |
Breast | Â | Â | Â | Â | Â | Â |
   Female (n = 133) | 15.6 (6.5) | 7.9 (4.3) | 5.0 (4.4) | 21.3 (21.3) | 4.5(.9) | 3.8(3.4) |
   Male (n = 1) | 10.0 (na) | 5.0 (na) | 2.0 (na) | 0 (na) | 5.0 (na) | 5.0 (na) |
Melanoma | Â | Â | Â | Â | Â | Â |
   Female (n = 9) | 14.5 (7.1) | 8.3 (5.1) | 2.1 (3.4) | 12.3 (21.5) | 4.7 (.5) | 5.0 (3.5) |
   Male (n = 12) | 13.2 (4.2) | 6.6 (1.8) | 3.9 (2.6) | 4.2 (5.2) | 4.6 (.7) | 1.7 (2.2) |
Head & Neck | Â | Â | Â | Â | Â | Â |
   Female (n = 12) | 26.1 (16.0) | 11.0 (3.7) | 8.7 (5.9) | 25.0 (21.9) | 4.3 (.8) | 5.6 (3.2) |
   Male (n = 18) | 15.3 (5.8) | 8.3 (4.0) | 6.6 (5.8) | 20.8 (24.7) | 4.5 (1.2) | 3.6 (3.1) |
Genito-Urinary (incl Prostate) | Â | Â | Â | Â | Â | Â |
   Female (n = 5) | 12.0 (2.8) | 6.2 (2.2) | 6.4 (3.8) | 17.4 (24.8) | 4.8 (.5) | 1.3 (1.5) |
   Male (n = 83) | 14.6 (6.5) | 7.4 (3.5) | 5.9 (5.1) | 14.6 (27.6) | 4.4 (1.2) | 2.8 (3.4) |